NASDAQ:NBIX | Insider Transactions — Page 11 | NEUROCRINE BIOSCIENCES INC

NBIX Insider Transactions — Page 11

1,692 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,001–1,100; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
BVF PARTNERS L P/ILTenPercentOwner2010-03-26Sale5,000.0$2.7
BVF INC/ILTenPercentOwner2010-03-26Sale5,000.0$2.7
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-26Sale5,000.0$2.7
BVF INVESTMENTS LLCOther2010-03-26Sale5,000.0$2.7
LAMPERT MARK NTenPercentOwner2010-03-26Sale5,000.0$2.7
BIOTECHNOLOGY VALUE FUND L POther2010-03-26Sale8,200.0$2.7
BVF PARTNERS L P/ILTenPercentOwner2010-03-26Sale8,200.0$2.7
BVF INC/ILTenPercentOwner2010-03-26Sale8,200.0$2.7
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-26Sale8,200.0$2.7
BVF INVESTMENTS LLCOther2010-03-26Sale8,200.0$2.7
LAMPERT MARK NTenPercentOwner2010-03-26Sale8,200.0$2.7
BIOTECHNOLOGY VALUE FUND L POther2010-03-25Sale179,000.0$2.7
BVF PARTNERS L P/ILTenPercentOwner2010-03-25Sale179,000.0$2.7
BVF INC/ILTenPercentOwner2010-03-25Sale179,000.0$2.7
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-25Sale179,000.0$2.7
BVF INVESTMENTS LLCOther2010-03-25Sale179,000.0$2.7
LAMPERT MARK NTenPercentOwner2010-03-25Sale179,000.0$2.7
BIOTECHNOLOGY VALUE FUND L POther2010-03-25Sale52,000.0$2.7
BVF PARTNERS L P/ILTenPercentOwner2010-03-25Sale52,000.0$2.7
BVF INC/ILTenPercentOwner2010-03-25Sale52,000.0$2.7
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-25Sale52,000.0$2.7
BVF INVESTMENTS LLCOther2010-03-25Sale52,000.0$2.7
LAMPERT MARK NTenPercentOwner2010-03-25Sale52,000.0$2.7
BIOTECHNOLOGY VALUE FUND L POther2010-03-25Sale73,800.0$2.7
BVF PARTNERS L P/ILTenPercentOwner2010-03-25Sale73,800.0$2.7
BVF INC/ILTenPercentOwner2010-03-25Sale73,800.0$2.7
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-25Sale73,800.0$2.7
BVF INVESTMENTS LLCOther2010-03-25Sale73,800.0$2.7
LAMPERT MARK NTenPercentOwner2010-03-25Sale73,800.0$2.7
BIOTECHNOLOGY VALUE FUND L POther2010-03-24Sale51,000.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2010-03-24Sale51,000.0$2.75
BVF INC/ILTenPercentOwner2010-03-24Sale51,000.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-24Sale51,000.0$2.75
BVF INVESTMENTS LLCOther2010-03-24Sale51,000.0$2.75
LAMPERT MARK NTenPercentOwner2010-03-24Sale51,000.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2010-03-24Sale15,000.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2010-03-24Sale15,000.0$2.75
BVF INC/ILTenPercentOwner2010-03-24Sale15,000.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-24Sale15,000.0$2.75
BVF INVESTMENTS LLCOther2010-03-24Sale15,000.0$2.75
LAMPERT MARK NTenPercentOwner2010-03-24Sale15,000.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2010-03-24Sale22,000.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2010-03-24Sale22,000.0$2.75
BVF INC/ILTenPercentOwner2010-03-24Sale22,000.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-24Sale22,000.0$2.75
BVF INVESTMENTS LLCOther2010-03-24Sale22,000.0$2.75
LAMPERT MARK NTenPercentOwner2010-03-24Sale22,000.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2010-03-23Sale17,000.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2010-03-23Sale17,000.0$2.75
BVF INC/ILTenPercentOwner2010-03-23Sale17,000.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-23Sale17,000.0$2.75
BVF INVESTMENTS LLCOther2010-03-23Sale17,000.0$2.75
LAMPERT MARK NTenPercentOwner2010-03-23Sale17,000.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2010-03-23Sale5,000.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2010-03-23Sale5,000.0$2.75
BVF INC/ILTenPercentOwner2010-03-23Sale5,000.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-23Sale5,000.0$2.75
BVF INVESTMENTS LLCOther2010-03-23Sale5,000.0$2.75
LAMPERT MARK NTenPercentOwner2010-03-23Sale5,000.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2010-03-23Sale7,000.0$2.75
BVF PARTNERS L P/ILTenPercentOwner2010-03-23Sale7,000.0$2.75
BVF INC/ILTenPercentOwner2010-03-23Sale7,000.0$2.75
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-23Sale7,000.0$2.75
BVF INVESTMENTS LLCOther2010-03-23Sale7,000.0$2.75
LAMPERT MARK NTenPercentOwner2010-03-23Sale7,000.0$2.75
BIOTECHNOLOGY VALUE FUND L POther2010-03-22Sale42,000.0$2.77
BVF PARTNERS L P/ILTenPercentOwner2010-03-22Sale42,000.0$2.77
BVF INC/ILTenPercentOwner2010-03-22Sale42,000.0$2.77
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-22Sale42,000.0$2.77
BVF INVESTMENTS LLCOther2010-03-22Sale42,000.0$2.77
LAMPERT MARK NTenPercentOwner2010-03-22Sale42,000.0$2.77
BIOTECHNOLOGY VALUE FUND L POther2010-03-22Sale12,000.0$2.77
BVF PARTNERS L P/ILTenPercentOwner2010-03-22Sale12,000.0$2.77
BVF INC/ILTenPercentOwner2010-03-22Sale12,000.0$2.77
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-22Sale12,000.0$2.77
BVF INVESTMENTS LLCOther2010-03-22Sale12,000.0$2.77
LAMPERT MARK NTenPercentOwner2010-03-22Sale12,000.0$2.77
BIOTECHNOLOGY VALUE FUND L POther2010-03-22Sale18,000.0$2.77
BVF PARTNERS L P/ILTenPercentOwner2010-03-22Sale18,000.0$2.77
BVF INC/ILTenPercentOwner2010-03-22Sale18,000.0$2.77
BIOTECHNOLOGY VALUE FUND II LPOther2010-03-22Sale18,000.0$2.77
BVF INVESTMENTS LLCOther2010-03-22Sale18,000.0$2.77
LAMPERT MARK NTenPercentOwner2010-03-22Sale18,000.0$2.77
GORMAN KEVIN CHARLESPresident and CEO2010-03-01Sale15,609.0$2.53
Coughlin Timothy PVP and Chief Financial Officer2010-03-01Sale12,650.0$2.53
VALEUR JENSEN MARGARET EEVP and General Counsel2010-03-01Sale12,490.0$2.53
OBrien Christopher FlintSr. VP & Chief Medical Officer2010-03-01Sale13,490.0$2.53
Grigoriadis Dimitri E.Vice President, Research2010-03-01Sale13,955.0$2.53
Bozigian Haig P.Sr Vice President, Development2010-03-01Sale14,090.0$2.53
VALEUR JENSEN MARGARET EEVP and General Counsel2010-01-12Sale8,697.0$2.52
Coughlin Timothy PVP and Chief Financial Officer2010-01-12Sale8,697.0$2.52
GORMAN KEVIN CHARLESPresident and CEO2010-01-12Sale9,445.0$2.52
OBrien Christopher FlintSr. VP & Chief Medical Officer2010-01-04Sale1,503.0$2.65
Bozigian Haig P.Sr Vice President, Development2010-01-04Sale751.0$2.64
Grigoriadis Dimitri E.Vice President, Research2010-01-04Sale1,503.0$2.67
MITCHELL W THOMASDirector2009-11-05Purchase900.0$2.17
OBrien Christopher FlintSr. VP & Chief Medical Officer2009-09-28Sale4,859.0$3.11
Grigoriadis Dimitri E.Vice President, Research2009-09-28Sale3,038.0$3.12
Bozigian Haig P.Sr Vice President, Development2009-09-28Sale3,642.0$3.11
GORMAN KEVIN CHARLESPresident and CEO2009-03-30Sale15,146.0$3.43